Back to REGN
VANGUARD CAPITAL MANAGEMENT LLC → REGN
VANGUARD CAPITAL MANAGEMENT LLC REGN Position History
Regeneron Pharmaceuticals, Inc. • Healthcare
Quarters held
4
Latest value
$4.9B
Q3 2026
Peak value
$5.1B
First seen
Q1 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2026 | $5.1B |
| Q1 2026 | $5.1B |
| Q2 2026 | $4.1B |
| Q3 2026 | $4.9B |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $4.9B | 6.52M | — | — |
| Q2 2026 | $4.1B | 6.63M | — | — |
| Q1 2026 | $5.1B | 6.65M | — | — |
| Q1 2026 | $5.1B | 6.65M | — | — |